Health Sciences In The Media

The NIH’s management of Long COVID research, an initiative dubbed RECOVER, for Researching COVID to Enhance Recovery, has come under fire from patient advocates and scientists who say it lacks transparency and is moving too slowly, a ponderous battleship when a fleet of hydroplanes are what’s needed.

The vast majority of the American West is struggling with enduring “mega drought” conditions some experts think will last until 2030 and that is creating perfect conditions for an incurable disease to spread.

According to a new study, adults who share a bed with their partners sleep better than those who sleep alone.

A new study published in the Journal of Health Economics suggests states that have legalized recreational use of marijuana show reduced demand for certain prescription drugs. A 2020 Mel and Enid Zuckerman College of Public Health study is mentioned.

University of Arizona Health Sciences researchers will evaluate factors affecting the secondary transmission of COVID-19 and influenza within households during the Arizona Household Virus Study, part of the Centers for Disease Control and Prevention’s Respiratory Virus Transmission Network.

CNN’s Dr. Sanjay Gupta writes about gun violence in the U.S. and the toll firearms take on the human body.

PANDA members hosted their 22nd benefit fashion show, raising funds for the Children’s Genome Sequencing Project included the purchase of the NovaSeq 6000, a rapid whole genome sequencing machine with which the Steele Children’s Research Center hopes to bring answers and potential cures to children and their families.

Moderna says that a new version of its vaccine appears to provide strong protection against the omicron variant.

With germs and bacteria transferring from bodies onto bedding, experts debate the need for a top sheet.

Continuing coverage: Rucaparib monotherapy significantly prolonged PFS compared with placebo in the first-line maintenance setting among women with advanced ovarian cancer, regardless of BRCA mutation and homologous recombination deficiency status.